How are you modifying your current sarcoma-directed therapy in the setting of the COVID-19 pandemic?
For example, would you consider switching to an outpatient regimen in lieu of AIM for metastatic soft tissue sarcoma?
Answer from: Radiation Oncologist at Academic Institution
Here are the guidelines at Fox Chase Cancer Center by Margaret von Mehren MD, @Krisha J. Howell , Jeffrey Farma MD, Sanjay Reddy MD, John Abraham, MD, and Stephanie Greco, MD
I. Management of STS during COVID-19 Pandemic:
During the current pandemic, care will need to be changed to allow for hospi...
Sign in or Register to read more